Not Tagged
Not Tagged
['nsclc', 'opera,(-operat)', 'sclc']
neoadjuvant io+chemo is becoming new soc for operable stage ii/iii #nsclc (n2), but not for n3. port is losing its role and neoadjuvant io+sabr is being studied in this setting. as a society, we need to move on quickly. #asco22 , 
Texas 4000 Distinguished Professor and Director, Stereotactic Ablative Radiotherapy Program, MD Anderson Cancer Center